![Psychedelic Bulletin #105 - UK Won't Foot the Bill for Spravato; Another KAP Provider Launches; Canadian Province Decriminalises Possession of MDMA and Other Drugs - Psychedelic Alpha Psychedelic Bulletin #105 - UK Won't Foot the Bill for Spravato; Another KAP Provider Launches; Canadian Province Decriminalises Possession of MDMA and Other Drugs - Psychedelic Alpha](https://psychedelicalpha.com/wp-content/uploads/2022/06/studio-image-3.jpg)
Psychedelic Bulletin #105 - UK Won't Foot the Bill for Spravato; Another KAP Provider Launches; Canadian Province Decriminalises Possession of MDMA and Other Drugs - Psychedelic Alpha
![Janssen Announces U.S. FDA Approval of SPRAVATO™ (esketamine) CIII Nasal Spray for Adults with Treatment-Resistant Depression (TRD) Who Have Cycled Through Multiple Treatments Without Relief Janssen Announces U.S. FDA Approval of SPRAVATO™ (esketamine) CIII Nasal Spray for Adults with Treatment-Resistant Depression (TRD) Who Have Cycled Through Multiple Treatments Without Relief](https://mma.prnewswire.com/media/831191/Janssen_Spravato.jpg)
Janssen Announces U.S. FDA Approval of SPRAVATO™ (esketamine) CIII Nasal Spray for Adults with Treatment-Resistant Depression (TRD) Who Have Cycled Through Multiple Treatments Without Relief
![A New Antidepressant Is Available In Canada - Toronto Ketamine Clinic | IV Ketamine Treatment in Toronto and Surrounding Areas A New Antidepressant Is Available In Canada - Toronto Ketamine Clinic | IV Ketamine Treatment in Toronto and Surrounding Areas](https://torontoketamineclinic.com/wp-content/uploads/2021/01/CHE05_WEB_FD_OPENER_Feature-1280x960-1.jpg)
A New Antidepressant Is Available In Canada - Toronto Ketamine Clinic | IV Ketamine Treatment in Toronto and Surrounding Areas
![No wriggle room for enantiomers: Canada's FCA upholds refusal to grant data protection for SPRAVATO® (esketamine) | Insights | Torys LLP No wriggle room for enantiomers: Canada's FCA upholds refusal to grant data protection for SPRAVATO® (esketamine) | Insights | Torys LLP](https://www.torys.com/-/media/project/zenith-tenant/zenith-site/professionals/2023/bio/fghij/f/fei_sue_bio.jpg?h=1000&iar=0&w=1000&hash=3F98A45F535BE09510AFA3EA1159EF3D)
No wriggle room for enantiomers: Canada's FCA upholds refusal to grant data protection for SPRAVATO® (esketamine) | Insights | Torys LLP
![Psychedelic Bulletin #125: New Data Boosts Spravato's Case; Bipartisan Breakthrough Therapies Act; Berkeley Could Decrim. Psychedelics; DEA Increases Production Quotas - Psychedelic Alpha Psychedelic Bulletin #125: New Data Boosts Spravato's Case; Bipartisan Breakthrough Therapies Act; Berkeley Could Decrim. Psychedelics; DEA Increases Production Quotas - Psychedelic Alpha](https://psychedelicalpha.com/wp-content/uploads/2022/12/New-Spravato-Data-1-1024x576.png)
Psychedelic Bulletin #125: New Data Boosts Spravato's Case; Bipartisan Breakthrough Therapies Act; Berkeley Could Decrim. Psychedelics; DEA Increases Production Quotas - Psychedelic Alpha
![Racing Beyond Racemic: A Look at Ketamine Drug Development Ahead of atai's PCN-101 Phase 2a Readout - Psychedelic Alpha Racing Beyond Racemic: A Look at Ketamine Drug Development Ahead of atai's PCN-101 Phase 2a Readout - Psychedelic Alpha](http://psychedelicalpha.com/wp-content/uploads/2022/11/Spravato-pricing-1.png)